Goldman Sachs Group Inc Bio N Tech Se Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Goldman Sachs Group Inc holds 146,584 shares of BNTX stock, worth $15.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

146,584

Previous 184,112 20.38%

Holding current value

$15.1 Million

Previous $19.6 Million 26.25%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$96.22 - $115.31 $3.61 Million - $4.33 Million	-37,528 Reduced 20.38%	146,584 $14.5 Million
Q2 2025 Aug 14, 2025	SELL	$86.65 - $120.54 $7.46 Million - $10.4 Million	-86,099 Reduced 31.86%	184,112 $19.6 Million
Q1 2025 May 16, 2025	SELL	$91.06 - $126.88 $8.2 Million - $11.4 Million	-90,000 Reduced 24.99%	270,211 $24.6 Million
Q1 2025 May 09, 2025	BUY	$91.06 - $126.88 $14.5 Million - $20.3 Million	159,741 Added 79.68%	360,211 $32.8 Million
Q4 2024 Feb 11, 2025	BUY	$99.72 - $122.68 $17 Million - $20.9 Million	170,126 Added 560.66%	200,470 $22.8 Million

Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $7.94 Million - $12.6 Million	-101,277 Reduced 76.95%	30,344 $3.6 Million
Q2 2024 Aug 13, 2024	SELL	$80.36 - $102.87 $2.45 Million - $3.13 Million	-30,461 Reduced 18.79%	131,621 $10.6 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $1.85 Million - $2.34 Million	-20,796 Reduced 11.37%	162,082 $15 Million
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $3.83 Million - $4.76 Million	42,177 Added 29.98%	182,878 $19.3 Million
Q3 2023 May 14, 2024	SELL	$98.5 - $125.08 $4.15 Million - $5.28 Million	-42,177 Reduced 23.06%	140,701 $15.3 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $6.6 Million - $8.38 Million	-67,030 Reduced 32.27%	140,701 $15.3 Million
Q2 2023 May 14, 2024	SELL	$102.58 - $129.66 $10.1 Million - $12.7 Million	-98,092 Reduced 32.07%	207,731 $22.4 Million
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $10.1 Million - $12.7 Million	-98,092 Reduced 32.07%	207,731 $22.4 Million
Q1 2023 May 14, 2024	BUY	$122.57 - $153.67 $18.4 Million - $23 Million	149,721 Added 95.91%	305,823 $38.1 Million
Q1 2023 May 11, 2023	BUY	$122.57 - $153.67 $18.4 Million - $23 Million	149,721 Added 95.91%	305,823 $38.1 Million
Q4 2022 May 14, 2024	SELL	$118.43 - $186.05 $3.75 Million - $5.9 Million	-31,699 Reduced 16.88%	156,102 $23.4 Million
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $3.75 Million - $5.9 Million	-31,699 Reduced 16.88%	156,102 $23.4 Million
Q3 2022 May 14, 2024	SELL	$127.65 - $183.11 $4.1 Million - $5.88 Million	-32,097 Reduced 14.6%	187,801 $25.3 Million
Q3 2022 Nov 10, 2022	SELL	$127.65 - $183.11 $4.1 Million - $5.88 Million	-32,097 Reduced 14.6%	187,801 $25.3 Million
Q2 2022 May 14, 2024	BUY	$123.25 - $186.24 $4.56 Million - $6.89 Million	37,020 Added 20.24%	219,898 $32.8 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $14.9 Million - $22.5 Million	-120,879 Reduced 35.47%	219,898 $32.8 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $1.55 Million - $2.85 Million	12,284 Added 3.74%	340,777 $58.1 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $20.7 Million - $34.7 Million	95,679 Added 41.1%	328,493 $84.7 Million
Q3 2021 Nov 10, 2021	BUY	$205.93 - $447.23 $47.9 Million - $104 Million	232,814 New	232,814 $63.6 Million

Others Institutions Holding BNTX

# of Institutions

319

Shares Held

43.6M

Call Options Held

1.15M

Put Options Held

1.36M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Bio N Tech Se Transaction History